ARCA biopharma Inc (ABIO)

4.17 +0.13  +3.22% NASDAQ Nov 25, 17:00 USD
View Full Chart
Price Chart
View All Events


Date Type Description
02/15/2021 Earnings ARCA Biopharma Inc Fourth Quarter Earnings Results for 2020
11/02/2020 Earnings ARCA Biopharma Inc Third Quarter Earnings Results for 2020
08/05/2020 Earnings ARCA Biopharma Inc Second Quarter Earnings Results for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: Colorado
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 15, 2021
  • Last Earnings Release: Nov. 02, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: ARCA biopharma Inc is a biopharmaceutical company. It applies precision medicine approach to develop genetically targeted therapies for cardiovascular diseases. The firm's lead product candidate is Gencaro. The company adopts genotype-directed comparative effectiveness trial of Bucindolol and Toprol-XL for prevention of symptomatic atrial fibrillation in patients with heart failure. It establishes long-term relationships with partners such as Medtronic, Laboratory Corporation of America and the University of Colorado.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.